posted on 2023-03-31, 01:22authored byStephanie Rossnagl, Hiba Ghura, Christopher Groth, Eva Altrock, Franz Jakob, Sarah Schott, Pauline Wimberger, Theresa Link, Jan Dominik Kuhlmann, Arnulf Stenzl, Jörg Hennenlotter, Tilmann Todenhöfer, Markus Rojewski, Karen Bieback, Inaam A. Nakchbandi
<p>Supplementary-Figure 4 Absolute numbers of HSPCs and MSCs after G-CSF and G-CSF+PTH/ZA treatment and in Mx 1fl/fl knockout mice (A) The absolute number of HSPCs per femur was lower after treatment with G-CSF, whereas the number of MSCs was higher, n=12/14 in 3 experiments. (B) Addition of PTH/ZA to G-CSF did not affect HSPCs further, but reduced the absolute number of MSCs, n=14/14 in 3 experiments. (C) Conditional deletion of integrin 1 (Mx 1fl/fl) in the bone marrow had no effect on HSPCs, but led to increased absolute numbers of MSCs, n=6/9 in 2 experiments. Expression of MSC markers on low-passage human MSCs (D) In order to evaluate potential MSC markers, adherent human bone marrow cells (passages 0 or 1) were dissociated from the plates and stained for flow cytometry analysis. Shown is a graph summarizing the findings. In addition, in each panel the unstained control is shown on the left and the bone marrow staining on the right (E). The cells were 79% positive for CD31, 91% positive for CD44, 22% positive for CD56, 95% positive for CD73, 59% positive for CD140b, 61% positive for CD144, 72% positive for CD146, 87% positive for CD271, 87% positive for CD349, 90% positive for FAP, 90% positive for MSCA1, and 92% positive for Stro1; n=4 different aspirates.</p>